Related Experiment Video

Updated: Aug 15, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Drug therapy for hypertension in hemodialysis patients

M P Hörl1, M Tepel

  • 1Department of Medicine, University Hospital Benjamin Franklin, Free University Berlin, Germany. matthias.hoerl@web.de

Minerva Medica
|September 24, 2005
PubMed

Insights

Hypertension is common in hemodialysis patients, impacting survival. Optimal blood pressure control and specific antihypertensive drug guidelines are crucial for end-stage renal disease (ESRD) patients to improve long-term outcomes.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Pharmacology

Background:

  • Hypertension is highly prevalent in chronic hemodialysis patients, significantly increasing cardiovascular morbidity and mortality.
  • Achieving normalized blood pressure in this population is linked to improved long-term survival rates.
  • Current antihypertensive drug options include ACE inhibitors, ARBs, beta-blockers, and diuretics, yet specific guidelines for ESRD patients are lacking.

Purpose of the Study:

  • To review current understanding of hypertension management in chronic hemodialysis patients.
  • To highlight the need for evidence-based guidelines for antihypertensive drug selection in ESRD.
  • To identify gaps in knowledge regarding optimal pharmacotherapy for hypertension in this vulnerable group.

Main Methods:

  • Review of existing literature and survival analyses concerning hypertension in hemodialysis patients.
  • Analysis of studies comparing different classes of antihypertensive medications.
  • Identification of patient populations and outcomes associated with various drug therapies.

Main Results:

  • Some studies favor angiotensin-converting enzyme (ACE) inhibitors for improved survival.
  • Calcium channel blockers have been associated with a reduced risk of cardiovascular mortality in certain analyses.
  • Beta-blockers are considered potentially ideal due to increased sympathetic nerve activity in ESRD, but hypertension control remains inadequate for most patients.

Conclusions:

  • Hypertension management in chronic hemodialysis patients is often suboptimal.
  • Randomized controlled trials are essential to determine the most effective antihypertensive agents for ESRD patients on maintenance hemodialysis.
  • Establishing clear guidelines for antihypertensive therapy is critical for improving patient outcomes and survival.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...